NCT/Study#
NA /
CP-NEXI-002-01
A Phase 1 / 2 Study To Evaluate The Safety And Tolerability Of Adoptively Transferred Autologous T Cells In Patients With Relapsed Refractory Multiple Myeloma
DISEASE GROUP:
Multiple Myeloma
current phase:
Phase 1/2
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
